Prime Medicine Inc (PRME)

02:06 AM

FY2024 EPS Forecast for Prime Medicine Increased by Analyst - Defense World

02:06 AM

Nov 16, 2024

FY2024 EPS Estimates for Prime Medicine Reduced by Analyst - Defense World

Nov 16, 2024

Nov 16, 2024

Wedbush Forecasts Prime Medicine FY2024 Earnings - Defense World

Nov 16, 2024

Nov 16, 2024

Prime Medicine, Inc. (NYSE:PRME) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Nov 16, 2024

Nov 16, 2024

Prime Medicine (NYSE:PRME) Raised to Sell at StockNews.com - Defense World

Nov 16, 2024

Nov 15, 2024

Layoff Tracker: Sensei to Cut 46% of Workforce, Close Research Site - BioSpace

Nov 15, 2024

Nov 15, 2024

FY2024 EPS Estimate for Prime Medicine Decreased by Analyst - MarketBeat

Nov 15, 2024

Nov 15, 2024

Chardan Capital Issues Pessimistic Forecast for Prime Medicine (NYSE:PRME) Stock Price - Defense World

Nov 15, 2024

Nov 15, 2024

Prime Medicine (NYSE:PRME) Earns “Buy” Rating from HC Wainwright - Defense World

Nov 15, 2024

Nov 14, 2024

Is Prime Medicine (NASDAQ:PRME) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Nov 14, 2024

Nov 13, 2024

Prime Medicine Reports Q3 2024 Financial Progress - TipRanks

Nov 13, 2024

Nov 13, 2024

Prime Medicine's (PRME) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Nov 13, 2024

Nov 12, 2024

FMR LLC Bolsters Stake in Prime Medicine Inc - GuruFocus.com

Nov 12, 2024

Nov 12, 2024

Prime Medicine, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024

Nov 12, 2024

Prime Medicine Reports Third Quarter 2024 Financial Results and Provides Business Updates - GlobeNewswire

Nov 12, 2024

Nov 08, 2024

ARK Investment Management LLC Lowers Stock Position in Prime Medicine, Inc. (NYSE:PRME) - MarketBeat

Nov 08, 2024

Nov 06, 2024

Prime Medicine to Participate in Upcoming Investor Conferences - The Manila Times

Nov 06, 2024

Oct 27, 2024

Head to Head Review: Prime Medicine (NYSE:PRME) and Invivyd (NASDAQ:IVVD) - Defense World

Oct 27, 2024

Oct 25, 2024

Prime Medicine (NYSE:PRME) Receives Buy Rating from HC Wainwright - MarketBeat

Oct 25, 2024

Oct 25, 2024

Prime Medicine Spat with Tessera Rumbles on at ESGCT - Genetic Engineering & Biotechnology News

Oct 25, 2024

Oct 25, 2024

Brokerages Set Prime Medicine, Inc. (NYSE:PRME) Price Target at $13.50 - Defense World

Oct 25, 2024

Oct 24, 2024

Prime Medicine Presents In Vivo Proof-of-Concept Data - GlobeNewswire

Oct 24, 2024

Oct 24, 2024

Prime Medicine Advances Gene Editing for Liver Diseases - TipRanks

Oct 24, 2024

Oct 24, 2024

Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson’s Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress - Yahoo Finance

Oct 24, 2024

Oct 23, 2024

Deals In Depth: September 2024 - Citeline News & Insights

Oct 23, 2024

Oct 22, 2024

Prime Medicine (NYSE:PRME) Shares Down 4.6%Should You Sell? - MarketBeat

Oct 22, 2024

Oct 22, 2024

Prime Medicine, Inc. (NYSE:PRME) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Oct 22, 2024

Oct 18, 2024

Prime Medicine (NYSE:PRME) Stock Price Up 15%What's Next? - MarketBeat

Oct 18, 2024

Oct 16, 2024

Why I Keep Buying These 14 Incredible Growth Stocks - The Motley Fool

Oct 16, 2024

Oct 15, 2024

There is no doubt that Prime Medicine Inc (PRME) ticks all the boxes. - SETE News

Oct 15, 2024

Oct 15, 2024

Prime Medicine to Highlight New Preclinical Data, Including - GlobeNewswire

Oct 15, 2024

Oct 15, 2024

Market Watch Highlights: Prime Medicine Inc (PRME) Ends on an Upturn Note at 3.73 - The Dwinnex

Oct 15, 2024

Oct 15, 2024

Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson’s Disease, at Upcoming Scientific Meetings - Yahoo Finance

Oct 15, 2024

Oct 14, 2024

Prime Medicine Inc (PRME) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News

Oct 14, 2024

Oct 11, 2024

Prime Medicine, Inc. (NYSE:PRME) Shares Purchased by Millennium Management LLC - MarketBeat

Oct 11, 2024

Oct 10, 2024

The Significance of Moving Averages in Prime Medicine Inc Inc. (PRME) Price Performance - The InvestChronicle

Oct 10, 2024

Oct 09, 2024

Check out these key findings about Prime Medicine Inc (PRME) - SETE News

Oct 09, 2024

Oct 09, 2024

Prime Medicine Inc [PRME] Investment Guide: What You Need to Know - Knox Daily

Oct 09, 2024

Oct 09, 2024

Prime Medicine lays off workers as it trims pipeline - STAT

Oct 09, 2024

Oct 07, 2024

Insider’s View: Deciphering Prime Medicine Inc (PRME)’s Financial Health Through Ratios - The Dwinnex

Oct 07, 2024

Oct 04, 2024

News: CMN Weekly (4 October 2024)Your Weekly CRISPR Medicine News - CRISPR Medicine News

Oct 04, 2024

Oct 02, 2024

Prime Medicine, MINISO Group, Li Auto, Weibo And Other Big Stocks Moving Higher On Monday - MSN

Oct 02, 2024

Oct 02, 2024

A new trading data show Prime Medicine Inc (PRME) is showing positive returns. - SETE News

Oct 02, 2024

Oct 02, 2024

Prime Medicine Inc (PRME) rating initates by H.C. Wainwright - Knox Daily

Oct 02, 2024

Oct 02, 2024

Prime Medicine, Inc. Expected to Earn Q4 2024 Earnings of ($0.28) Per Share (NYSE:PRME) - Defense World

Oct 02, 2024

Oct 02, 2024

Prime Medicine (NYSE:PRME) Given "Buy" Rating at HC Wainwright - MarketBeat

Oct 02, 2024

Oct 02, 2024

Prime Medicine’s (PRME) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Oct 02, 2024

Oct 02, 2024

Q4 2024 EPS Estimates for Prime Medicine, Inc. (NYSE:PRME) Lifted by Wedbush - MarketBeat

Oct 02, 2024

Oct 01, 2024

PRME Stock Rises 11.8% on Collaboration With Bristol Myers - Zacks Investment Research

Oct 01, 2024

Oct 01, 2024

BMS Inserts Cash Into Prime Medicine’s Gene-Editing Ambitions - Scrip

Oct 01, 2024

Oct 01, 2024

BMS and Prime ink potential $3.5bn deal to develop T cell therapies - Yahoo Finance

Oct 01, 2024